Summary Card
Level of Evidence: Randomized Controlled Trial
Background: Infantile hemangiomas are benign vascular tumors affecting 5-10% of infants. Oral propranolol is a potential treatment option.
Methods: A double-blind, randomized trial compared oral propranolol (3 mg/kg/day) to placebo in 460 infants with hemangioma.
Results: Propranolol achieved successful treatment in 60% of participants, compared to 4% in the placebo group.
Conclusion: Oral propranolol is an effective and well-tolerated treatment for infantile hemangiomas, but further research is needed for optimal treatment duration and long-term effects.
⚡
The complete journal club analysis is for thePlasticsPro users.
This is for thePlasticsPro
Join the Club to enjoy unlimited access to all of thePlasticsFella.
Join the Club
Already have an account?
Sign in